14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.61 $4.97 Friday, 3rd May 2024 ALDX stock ended at $4.16. This is 1.19% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.28% from a day low at $4.08 to a day high of $4.29.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Jun 13, 2022 $3.41 $3.54 $3.28 $3.34 1 151 876
Jun 10, 2022 $3.74 $3.76 $3.50 $3.57 1 054 062
Jun 09, 2022 $3.59 $4.03 $3.42 $3.86 2 786 730
Jun 08, 2022 $3.85 $3.87 $3.46 $3.50 5 054 093
Jun 07, 2022 $3.16 $3.67 $3.16 $3.60 807 556
Jun 06, 2022 $3.13 $3.28 $3.07 $3.21 535 717
Jun 03, 2022 $3.05 $3.18 $3.00 $3.05 526 236
Jun 02, 2022 $2.93 $3.10 $2.88 $3.05 308 931
Jun 01, 2022 $3.09 $3.17 $2.86 $2.94 437 959
May 31, 2022 $3.10 $3.17 $3.01 $3.09 384 434
May 27, 2022 $2.76 $3.11 $2.75 $3.10 417 099
May 26, 2022 $2.78 $2.83 $2.74 $2.76 371 167
May 25, 2022 $2.70 $2.85 $2.69 $2.78 620 116
May 24, 2022 $2.83 $2.83 $2.65 $2.69 541 705
May 23, 2022 $2.86 $2.90 $2.69 $2.83 490 133
May 20, 2022 $2.68 $2.86 $2.60 $2.85 835 201
May 19, 2022 $2.44 $2.64 $2.36 $2.62 694 413
May 18, 2022 $2.62 $2.62 $2.45 $2.46 629 667
May 17, 2022 $2.58 $2.65 $2.53 $2.64 780 201
May 16, 2022 $2.49 $2.56 $2.43 $2.50 474 230
May 13, 2022 $2.53 $2.57 $2.48 $2.49 518 404
May 12, 2022 $2.41 $2.54 $2.36 $2.43 847 345
May 11, 2022 $2.56 $2.81 $2.40 $2.44 829 180
May 10, 2022 $2.55 $2.81 $2.55 $2.63 1 325 266
May 09, 2022 $2.63 $2.70 $2.43 $2.47 1 125 016
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT